scorecardresearch
Thursday, April 25, 2024
TopicPharma sector

Topic: Pharma sector

Eli Lilly inks licensing deal with Cipla, Lupin, Sun Pharma for Baricitinib to treat Covid

Baricitinib is currently registered in India for the treatment of moderate to severe active rheumatoid arthritis in adult patients.

India-China flight disruptions could hurt global pharma supply chains

The US relies heavily on India to stock its medicine cabinets, and any slowdown in output could leave pharmacies short of drugs used regularly by millions of Americans.

India approaches US firms seeking investment in country’s pharmaceutical, medical sector

Last week, India's Ambassador to the US Taranjit Singh Sandhu held virtual meetings with top US pharma companies, including Pfizer, and said India is seeking to encourage investments.

Pharma industry warns of Covid drug shortages as raw materials prices surge 200%

Pharma firms say suspension of cargo from China has resulted hoarding, driving up prices of raw materials, seek govt intervention immediately.

Faced with drugs shortage, Indian pharma asks envoy to stop Chinese cargo suspension

On 26 April, China suspended for 15 days cargo flights by Sichuan Airlines that transports medical supplies to India. India imports 70% of its pharmaceutical raw materials from China.

Demand for Covid vaccines, hydroxychloroquine pushes India’s pharma exports to 5-year high

Exports are expected to rise by over 16% this fiscal. The industry recorded less than 3% growth in 2014-15 and 2017-18. In 2016-17, there was negative growth of 0.59%.

India ‘pharmacy to world’ but sector is fragmented, unorganised — foreign firms’ lobby says

Report highlights loopholes in distribution chain of pharma products, but also stresses on India’s important role in ‘promoting local and global health goals’.

Cipla, Sun Pharma, Lupin on drug price watchdog’s new list of firms ‘overcharging consumers’

NPPA has issued a list of  ‘overcharging cases’ under litigation, which includes matters dating back to 1997 & those where firms have moved court against the allegations.

To boost pharma investments, Modi govt sets up panel to revamp policies & draw up action plan

The expert panel, consisting of 5 members from the industry and a govt official, has highlighted archaic labour laws & flawed definitions of fast-tracking mechanisms as hiccups. 

Govt repeats warning to pharma firms, says don’t ‘promote products in unethical ways’

In a letter to pharma organisations, govt mentioned a complaint against an event to be held by ‘Indian Psychotropic Society’. Industry members say they have never heard the name.

On Camera

Congress attacks on Ambani-Adani won’t fly. Nature of wealth has changed since Indira days

Sam Pitroda can help Congress by pasting some strong, sticky tape all over his mouth and then spending the rest of the 2024 Lok Sabha election campaign in silence. He has done enough damage already.

Economists vs statisticians — the battle being fought over the soul of India’s GDP data

Economists say there are weaknesses in India’s GDP data. But statisticians claim the accusations are based on flawed understanding, saying while GDP has problems, the economists are looking in the wrong places.

What is ‘ROCKS’, India’s first air-launched quasi-ballistic missile

A next generation extended stand-off air-to-surface missile test fired by IAF, ROCKS has been designed & manufactured by Israeli defence major Rafael, keeping India’s needs in mind.

These 6 states are key for Modi’s ‘400 paar’ target. They’re also where Opposition can stop him

While this contest looks so predictable in large swathes of our political landscape, it is also more keenly contested than 2019 in some states.